Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
7 Patents
#71 in Oslo
#239 in Norway
Vaccibody as
Forward Citations = 8
12 inventors:
Vaccibody as
% Expired Patents = 14.3
CIPO Patents = 1
EPO Patents = 3
Trademarks = 1
Forward Citations = 8
Loading Chart...
Loading Chart...
12 inventors (with patents filed for the assignee):
Agnete Brunsvik Fredriksen (6 out of 12 patents)
Bjarne Bogen (4 out of 16 patents)
Inger Sandlie (3 out of 19 patents)
4. Stine Granum (2 out of 3 patents)
5. Pier Adelchi Ruffini (1 out of 4 patents)
6. Monika Sekelja (1 out of 5 patents)
7. Ole Henrik Brekke (1 out of 1 patent)
8. Ali Areffard (1 out of 1 patent)
9. Mona Mari Lindeberg (1 out of 1 patent)
10. Agnete Fredriksen Brunsvik (1 out of 1 patent)
11. Karoline Schjetne (1 out of 3 patents)
12. Elisabeth Stubsrud (1 out of 2 patents)
7 patents:
Company Overview
Vaccibody is a biotechnology company focused on the development of novel cancer vaccines. Their proprietary platform technology utilizes virus-like particles and individual tumor antigens to stimulate a potent immune response against cancer cells. Vaccibody's lead product candidate, VB10.NEO, is currently in clinical trials for the treatment of solid tumors.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vaccibody as. Retrieved from https://idiyas.com/company/vaccibody-as
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]